Review: taking Wellbutrin and Trilafon together


Summary

Drug interactions are reported among people who take Wellbutrin and Trilafon together. This review analyzes the effectiveness and drug interactions between Wellbutrin and Trilafon. It is created by eHealthMe based on reports of 180 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Wellbutrin and Trilafon >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Wellbutrin

Wellbutrin has active ingredients of bupropion. It is often used in depression. (latest outcomes from Wellbutrin 54,657 users)

Trilafon

Trilafon has active ingredients of perphenazine. It is often used in psychotic disorder. (latest outcomes from Trilafon 1,020 users)

On Jul, 18, 2016

180 people who take Wellbutrin, Trilafon are studied.


Number of reports submitted per year:

Wellbutrin and Trilafon drug interactions.

Drug effectiveness over time:

Wellbutrin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (6 of 6 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Trilafon:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (7 of 7 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Wellbutrin:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (8 of 8 people)
Trilafon:
  • female: 100.0% - (1 of 1 people)
  • male: 87.0% - (7 of 8 people)

Drug effectiveness by age:

Wellbutrin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (6 of 6 people)
  • 60+: 0.0% - (0 of 0 people)
Trilafon:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 100.0% - (6 of 6 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • supraventricular tachycardia
  • pleurothotonus
1 - 6 months:
  • akathisia
  • galactorrhoea
6 - 12 months:
  • akathisia
1 - 2 years:
  • calculus urethral
  • flank pain
  • obstruction gastric
  • pain
  • pancreatitis
  • pancreatitis acute
  • type 2 diabetes mellitus
  • urethral stenosis
  • weight increased
  • blood cholesterol increased
2 - 5 years:
  • angioedema
  • swollen tongue
  • vision blurred
  • headache
  • lightheadedness - dizzy
  • nausea
  • neck tightness
  • pain - back
  • cholecystitis acute
  • diabetic retinopathy
5 - 10 years:
  • dysphonia
  • fatigue
  • headache
  • mastitis
  • angioedema
  • swollen tongue
  • abdominal pain upper
  • chest pain
  • disturbance in attention
  • dysphagia
10+ years:
  • hyperglycaemia
  • obesity
  • tardive dyskinesia
  • weight increased
not specified:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • hyperlipidaemia
  • arthralgia
  • pain
  • weight increased
  • anaemia
  • anxiety
  • back pain
  • injury

Most common drug interactions by gender *:

female:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • hyperlipidaemia
  • arthralgia
  • anxiety
  • anaemia
  • uterine leiomyoma
  • back pain
  • injury
  • pain
male:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • weight increased
  • pancreatitis
  • angioedema
  • pancreatitis acute
  • swollen tongue
  • diabetes mellitus inadequate control
  • mood swings
  • obstruction gastric

Most common drug interactions by age *:

0-1:
  • nephrolithiasis
  • obstruction gastric
  • pancreatitis
  • type 2 diabetes mellitus
  • urethral stenosis
  • weight increased
20-29:
  • blood cholesterol increased
  • blood triglycerides increased
  • type 2 diabetes mellitus
  • diabetic neuropathy
  • ballismus
  • choreoathetosis
  • dysarthria
  • dyskinesia
  • dystonia
  • gait disturbance
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • blood triglycerides increased
  • depression
  • diabetes mellitus inadequate control
  • diabetic ketoacidosis
  • uterine leiomyoma
  • vision blurred
  • weight increased
  • abdominal pain
40-49:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • weight increased
  • chest pain
  • hyperglycaemia
  • blood cholesterol increased
  • tardive dyskinesia
  • vomiting
  • hyperlipidaemia
  • convulsion
50-59:
  • pain
  • anaemia
  • anxiety
  • injury
  • anhedonia
  • arthralgia
  • back pain
  • disability
  • exostosis
  • gingival disorder
60+:
  • supraventricular tachycardia
  • cough
  • acute myocardial infarction
  • chest pain
  • diabetes mellitus
  • drug effect decreased
  • fatigue
  • feeling abnormal
  • insomnia
  • sleep disorder

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Wellbutrin and Trilafon?

Can you answer these questions?

More questions for: Wellbutrin, Trilafon

You may be interested in these reviews

More reviews for: Wellbutrin, Trilafon

On eHealthMe, Wellbutrin (bupropion) is often used to treat depression. Trilafon (perphenazine) is often used to treat psychotic disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.